Drugs / Biotin RBCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00731588 | Jun 2008 → Mar 2017 | neonatal anemia | John A Widness | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biotin RBCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00731588 ↗ |
| Known as | BioRBCs | “We report RCS measured in vivo using RBCs labeled with several densities of biotin (BioRBCs).” PMID 21062290 ↗ Nov 2010 |
| Route | Intravenous | “An IV is inserted for the reinfusion of the biotinylated RBCs.” NCT00731588 ↗ |